Cytomegalovirus viral load at initiation of pre‐emptive antiviral therapy impacts cytomegalovirus dynamics in pediatric allogeneic hematopoietic cell transplantation recipients
Transplant Infectious Disease · 2024
DOI: 10.1111/tid.14358 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transplant Infectious Disease, 2024. Verfasst von Valentina Gutierrez und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Division of Infectious Disease and Host Defense, Nationwide Children's Hospital, Columbus, Ohio, USA. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Cytomegalovirus Infections, Viral Load, Antiviral Agents. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Cytomegalovirus (CMV) contributes to morbidity and mortality in allogeneic hematopoietic cell transplantation (allo‐HCT) recipients. Pre‐emptive antiviral therapy (PET) reduces the incidence of CMV end‐organ disease (EOD), though relevant viral thresholds to initiate PET remain undefined. We evaluated the impact of viral loads (VLs) at PET initiation on virologic and clinical outcomes following pediatric allo‐HCT.
Methods
Single‐center retrospective cohort analysis of children who underwent their first allo‐HCT from January 2014 to December 2020. Weekly quantitative plasma CMV polymerase chain reaction was performed until Day +100 and PET was initiated once VL exceeded a pre‐defined threshold per institutional guidelines. Patients were followed for 1‐year post‐HCT to evaluate virologic and clinical outcomes including end‐organ disease (EOD), overall survival (OS), and non‐relapse mortality (NRM).
Results
Among 146 allo‐HCT recipients, CMV DNAemia occurred in 40 patients (27%) at a median of 15 days post‐HCT (interquartile range 6–28.5). Ten percent ( n = 4) had spontaneous resolution of DNAemia, while 90% ( n = 36) required PET. PET initiated when CMV VL was ≥ 1000 IU/mL ( n = 21) vs when VL < 1000 IU/mL ( n = 15) resulted in higher peak CMV VL (12,670 vs. 1284 IU/mL, p = 0.0001) and longer time to CMV DNAemia resolution (36 vs. 24 days, p = 0.035). There were no differences in EOD, OS, or NRM at 12 months post‐HCT based on VL at PET initiation.
Conclusions
Initiating PET when CMV VL was ≥1000 IU/mL resulted in significantly higher peak VL and prolonged DNAemia, with no differences in EOD, OS, or NRM at 12 months post pediatric HCT. image
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Division of Infectious Disease and Host Defense, Nationwide Children's Hospital, Columbus, Ohio, USA.
- Departamento de Enfermedades Infecciosas e Inmunología Pediátrica, Pontificia Universidad Católica de Chile, Santiago, Chile.
- Division of Hematology/Oncology/Blood and Marrow Transplantation, Nationwide Children's Hospital, Columbus, Ohio, USA.
- Department of Pediatrics, The Ohio State University College of Medicine, Columbus, Ohio, USA.
ORCID-Profile: Monica I Ardura, Eunkyung Song
Zitieren
APA
Gutierrez, V., Stanek, J., Ardura, M. I., & Song, E. (2024). Cytomegalovirus viral load at initiation of pre‐emptive antiviral therapy impacts cytomegalovirus dynamics in pediatric allogeneic hematopoietic cell transplantation recipients. Transplant Infectious Disease. https://doi.org/10.1111/tid.14358
Vancouver
Gutierrez V, Stanek J, Ardura MI, Song E. Cytomegalovirus viral load at initiation of pre‐emptive antiviral therapy impacts cytomegalovirus dynamics in pediatric allogeneic hematopoietic cell transplantation recipients. Transplant Infectious Disease. 2024. doi:10.1111/tid.14358
BibTeX
@article{Gutierrez2024,
author = {Gutierrez, Valentina and Stanek, Joseph and Ardura, Monica I and Song, Eunkyung},
title = {Cytomegalovirus viral load at initiation of pre‐emptive antiviral therapy impacts cytomegalovirus dynamics in pediatric allogeneic hematopoietic cell transplantation recipients},
journal = {Transplant Infectious Disease},
year = {2024},
doi = {10.1111/tid.14358}
}
EUVIMED